Concepts (249)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Rotavirus | 48 | 2013 | 497 | 3.420 |
Why?
|
| Rotavirus Infections | 17 | 2013 | 353 | 1.230 |
Why?
|
| RNA, Viral | 24 | 2011 | 541 | 1.220 |
Why?
|
| Antigens, Viral | 16 | 2007 | 436 | 1.040 |
Why?
|
| Reoviridae | 23 | 1994 | 38 | 1.020 |
Why?
|
| Genes, Viral | 20 | 1998 | 183 | 0.920 |
Why?
|
| Capsid | 13 | 2001 | 142 | 0.870 |
Why?
|
| Virus Replication | 18 | 2011 | 603 | 0.770 |
Why?
|
| Capsid Proteins | 13 | 2013 | 181 | 0.760 |
Why?
|
| Bacteriophages | 4 | 2021 | 77 | 0.630 |
Why?
|
| Genome, Viral | 5 | 2017 | 171 | 0.580 |
Why?
|
| Recombination, Genetic | 19 | 2002 | 441 | 0.550 |
Why?
|
| Extraintestinal Pathogenic Escherichia coli | 3 | 2021 | 24 | 0.470 |
Why?
|
| Mutation | 22 | 2011 | 5771 | 0.430 |
Why?
|
| Bluetongue virus | 6 | 1989 | 9 | 0.370 |
Why?
|
| Reassortant Viruses | 5 | 2011 | 34 | 0.340 |
Why?
|
| Microbial Viability | 3 | 2021 | 41 | 0.330 |
Why?
|
| Temperature | 20 | 2011 | 306 | 0.330 |
Why?
|
| Viremia | 2 | 2007 | 126 | 0.300 |
Why?
|
| Viral Nonstructural Proteins | 5 | 2003 | 193 | 0.290 |
Why?
|
| Suppression, Genetic | 6 | 1998 | 43 | 0.290 |
Why?
|
| Phage Therapy | 3 | 2021 | 24 | 0.280 |
Why?
|
| Polysaccharides | 2 | 2021 | 143 | 0.270 |
Why?
|
| Animals | 48 | 2021 | 33714 | 0.260 |
Why?
|
| Chromosome Mapping | 6 | 2011 | 1081 | 0.260 |
Why?
|
| Escherichia coli | 3 | 2021 | 978 | 0.230 |
Why?
|
| Drug Resistance, Multiple, Bacterial | 3 | 2021 | 149 | 0.210 |
Why?
|
| Intestines | 4 | 2003 | 571 | 0.200 |
Why?
|
| Promoter Regions, Genetic | 2 | 1996 | 1336 | 0.200 |
Why?
|
| Gastroenteritis | 1 | 2004 | 341 | 0.190 |
Why?
|
| Lymph Nodes | 1 | 2003 | 375 | 0.190 |
Why?
|
| Blood | 2 | 2021 | 105 | 0.190 |
Why?
|
| Cell Line | 14 | 2002 | 2772 | 0.190 |
Why?
|
| Viral Tail Proteins | 1 | 2021 | 7 | 0.190 |
Why?
|
| Heparan Sulfate Proteoglycans | 1 | 2021 | 17 | 0.180 |
Why?
|
| Viral Proteins | 8 | 1994 | 347 | 0.180 |
Why?
|
| Microbial Interactions | 1 | 2021 | 16 | 0.180 |
Why?
|
| Baculoviridae | 3 | 1996 | 64 | 0.170 |
Why?
|
| Prosthesis-Related Infections | 1 | 2021 | 176 | 0.160 |
Why?
|
| Anti-Bacterial Agents | 2 | 2021 | 2397 | 0.160 |
Why?
|
| Liver | 3 | 2004 | 1734 | 0.160 |
Why?
|
| Gastrointestinal Tract | 1 | 2021 | 208 | 0.160 |
Why?
|
| Coliphages | 1 | 2018 | 6 | 0.150 |
Why?
|
| Bacteriolysis | 1 | 2018 | 8 | 0.150 |
Why?
|
| Molecular Sequence Data | 6 | 2011 | 3868 | 0.150 |
Why?
|
| Orthoreovirus | 1 | 1998 | 4 | 0.150 |
Why?
|
| RNA, Double-Stranded | 8 | 1994 | 63 | 0.150 |
Why?
|
| Gastric Mucosa | 1 | 2021 | 483 | 0.140 |
Why?
|
| Metals | 1 | 2018 | 61 | 0.140 |
Why?
|
| Animals, Newborn | 3 | 2003 | 991 | 0.140 |
Why?
|
| Serotyping | 9 | 1993 | 178 | 0.140 |
Why?
|
| Trypsin | 5 | 2001 | 95 | 0.140 |
Why?
|
| Consensus Sequence | 1 | 1996 | 58 | 0.140 |
Why?
|
| Antibodies, Viral | 4 | 1998 | 1135 | 0.140 |
Why?
|
| RNA, Messenger | 5 | 1996 | 2814 | 0.130 |
Why?
|
| Kinetics | 9 | 1994 | 1313 | 0.130 |
Why?
|
| Bacteremia | 2 | 2017 | 406 | 0.130 |
Why?
|
| Mammalian orthoreovirus 3 | 5 | 1980 | 7 | 0.130 |
Why?
|
| Antibiosis | 1 | 2015 | 13 | 0.120 |
Why?
|
| Viral Structural Proteins | 3 | 1998 | 47 | 0.120 |
Why?
|
| Gene Expression Regulation, Viral | 1 | 1996 | 132 | 0.120 |
Why?
|
| Urinary Catheters | 1 | 2015 | 24 | 0.120 |
Why?
|
| Biodiversity | 1 | 2015 | 64 | 0.120 |
Why?
|
| Animals, Suckling | 3 | 1991 | 50 | 0.120 |
Why?
|
| Microbiota | 2 | 2021 | 388 | 0.120 |
Why?
|
| Vaccination | 4 | 2007 | 950 | 0.120 |
Why?
|
| Viral Plaque Assay | 7 | 1993 | 42 | 0.120 |
Why?
|
| Mice | 14 | 2021 | 17486 | 0.120 |
Why?
|
| Virion | 5 | 1996 | 149 | 0.120 |
Why?
|
| Crosses, Genetic | 8 | 1990 | 161 | 0.110 |
Why?
|
| Urinary Bladder | 1 | 2015 | 242 | 0.110 |
Why?
|
| Viral Core Proteins | 1 | 1993 | 22 | 0.110 |
Why?
|
| Cell Fusion | 1 | 1993 | 38 | 0.110 |
Why?
|
| Cattle Diseases | 1 | 1993 | 21 | 0.110 |
Why?
|
| Cattle | 7 | 2013 | 559 | 0.110 |
Why?
|
| Epitopes | 2 | 1992 | 430 | 0.100 |
Why?
|
| Viral Vaccines | 6 | 1998 | 325 | 0.100 |
Why?
|
| Heart-Assist Devices | 1 | 2021 | 1026 | 0.100 |
Why?
|
| Viral Fusion Proteins | 1 | 1993 | 77 | 0.100 |
Why?
|
| Diarrhea | 4 | 1991 | 316 | 0.100 |
Why?
|
| Chlorides | 1 | 1992 | 104 | 0.100 |
Why?
|
| Ceratopogonidae | 2 | 1989 | 2 | 0.100 |
Why?
|
| Bluetongue | 2 | 1989 | 2 | 0.090 |
Why?
|
| Sequence Analysis, DNA | 2 | 2011 | 1758 | 0.090 |
Why?
|
| Urinary Tract Infections | 1 | 2015 | 293 | 0.090 |
Why?
|
| Infant, Newborn, Diseases | 1 | 2013 | 171 | 0.090 |
Why?
|
| Superinfection | 1 | 1990 | 6 | 0.090 |
Why?
|
| Disease Models, Animal | 6 | 2018 | 4269 | 0.090 |
Why?
|
| Species Specificity | 7 | 1989 | 549 | 0.090 |
Why?
|
| Neutralization Tests | 4 | 1993 | 237 | 0.090 |
Why?
|
| Immunity, Maternally-Acquired | 1 | 1989 | 33 | 0.080 |
Why?
|
| Phenotype | 10 | 2003 | 4227 | 0.080 |
Why?
|
| Microscopy, Electron | 5 | 2001 | 391 | 0.080 |
Why?
|
| Heart Failure | 1 | 2021 | 2131 | 0.080 |
Why?
|
| Haplorhini | 5 | 1998 | 123 | 0.080 |
Why?
|
| Base Sequence | 4 | 2017 | 3091 | 0.080 |
Why?
|
| Escherichia coli Infections | 2 | 2021 | 191 | 0.070 |
Why?
|
| Vero Cells | 4 | 1993 | 110 | 0.070 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 5 | 1992 | 313 | 0.070 |
Why?
|
| Rotavirus Vaccines | 1 | 2007 | 71 | 0.070 |
Why?
|
| Mice, Inbred BALB C | 2 | 2021 | 1001 | 0.070 |
Why?
|
| Antibody Specificity | 3 | 1993 | 203 | 0.070 |
Why?
|
| Spodoptera | 2 | 1996 | 44 | 0.070 |
Why?
|
| Protein Conformation | 3 | 2003 | 835 | 0.060 |
Why?
|
| Humans | 18 | 2021 | 123184 | 0.060 |
Why?
|
| Amino Acid Sequence | 4 | 2002 | 2697 | 0.060 |
Why?
|
| Gastrointestinal Diseases | 1 | 2007 | 335 | 0.050 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 3 | 1992 | 812 | 0.050 |
Why?
|
| Genetic Markers | 2 | 1997 | 609 | 0.050 |
Why?
|
| Mammals | 1 | 2004 | 262 | 0.050 |
Why?
|
| Peptides | 4 | 1989 | 794 | 0.050 |
Why?
|
| Hydrogen-Ion Concentration | 2 | 1993 | 424 | 0.050 |
Why?
|
| Molecular Weight | 5 | 1994 | 392 | 0.050 |
Why?
|
| Genetic Fitness | 1 | 2021 | 32 | 0.050 |
Why?
|
| Adaptation, Biological | 1 | 2021 | 33 | 0.050 |
Why?
|
| Cells, Cultured | 4 | 1994 | 3046 | 0.050 |
Why?
|
| Specific Pathogen-Free Organisms | 1 | 2021 | 50 | 0.050 |
Why?
|
| Precipitin Tests | 2 | 1992 | 152 | 0.050 |
Why?
|
| Drug Antagonism | 1 | 2020 | 13 | 0.050 |
Why?
|
| Symbiosis | 1 | 2021 | 65 | 0.040 |
Why?
|
| Genotype | 4 | 1993 | 2539 | 0.040 |
Why?
|
| Germ-Free Life | 2 | 1993 | 59 | 0.040 |
Why?
|
| Administration, Oral | 1 | 2002 | 671 | 0.040 |
Why?
|
| In Vitro Techniques | 3 | 1991 | 966 | 0.040 |
Why?
|
| Drug Synergism | 1 | 2020 | 239 | 0.040 |
Why?
|
| Virulence Factors | 1 | 2021 | 172 | 0.040 |
Why?
|
| Cell Culture Techniques | 1 | 2021 | 287 | 0.040 |
Why?
|
| Genetic Complementation Test | 3 | 1983 | 86 | 0.040 |
Why?
|
| Macaca mulatta | 2 | 1998 | 494 | 0.040 |
Why?
|
| Morphogenesis | 2 | 1993 | 212 | 0.040 |
Why?
|
| Vaccines, Attenuated | 3 | 1998 | 173 | 0.040 |
Why?
|
| Organoids | 1 | 2021 | 277 | 0.040 |
Why?
|
| RNA-Binding Proteins | 1 | 2002 | 572 | 0.040 |
Why?
|
| Bacterial Load | 1 | 2018 | 30 | 0.040 |
Why?
|
| Hemagglutinins, Viral | 2 | 1993 | 25 | 0.040 |
Why?
|
| Selection, Genetic | 2 | 1991 | 155 | 0.040 |
Why?
|
| Staphylococcus aureus | 1 | 2021 | 456 | 0.040 |
Why?
|
| Insect Vectors | 2 | 1989 | 109 | 0.040 |
Why?
|
| Fluorescent Antibody Technique | 2 | 1989 | 462 | 0.040 |
Why?
|
| Vaccines, Synthetic | 1 | 1998 | 312 | 0.040 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2020 | 798 | 0.040 |
Why?
|
| Bacterial Translocation | 1 | 2017 | 24 | 0.040 |
Why?
|
| Templates, Genetic | 1 | 1996 | 95 | 0.030 |
Why?
|
| Molecular Biology | 1 | 1997 | 77 | 0.030 |
Why?
|
| Guanosine Triphosphate | 1 | 1996 | 47 | 0.030 |
Why?
|
| Biological Evolution | 1 | 1997 | 221 | 0.030 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 1996 | 317 | 0.030 |
Why?
|
| Cryoelectron Microscopy | 1 | 2017 | 212 | 0.030 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 1996 | 162 | 0.030 |
Why?
|
| Neutropenia | 1 | 2017 | 202 | 0.030 |
Why?
|
| Urine | 1 | 2015 | 88 | 0.030 |
Why?
|
| Viral Interference | 3 | 1983 | 6 | 0.030 |
Why?
|
| Urinary Catheterization | 1 | 2015 | 80 | 0.030 |
Why?
|
| Immunocompromised Host | 1 | 2017 | 300 | 0.030 |
Why?
|
| Antibodies, Monoclonal | 2 | 1992 | 1012 | 0.030 |
Why?
|
| Protein Processing, Post-Translational | 2 | 1994 | 354 | 0.030 |
Why?
|
| Sequence Deletion | 1 | 1996 | 527 | 0.030 |
Why?
|
| Catheters, Indwelling | 1 | 2015 | 155 | 0.030 |
Why?
|
| Chymotrypsin | 1 | 1993 | 16 | 0.030 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 2015 | 373 | 0.030 |
Why?
|
| Hemagglutination Tests | 1 | 2013 | 11 | 0.030 |
Why?
|
| Cell-Free System | 1 | 1993 | 106 | 0.030 |
Why?
|
| Alkalies | 1 | 1993 | 24 | 0.030 |
Why?
|
| Dactinomycin | 1 | 1993 | 67 | 0.030 |
Why?
|
| N-Acetylneuraminic Acid | 1 | 2013 | 27 | 0.030 |
Why?
|
| Immune Sera | 1 | 1993 | 95 | 0.030 |
Why?
|
| Cricetulus | 1 | 2013 | 97 | 0.030 |
Why?
|
| Virus Attachment | 1 | 2013 | 41 | 0.030 |
Why?
|
| Cloning, Molecular | 2 | 1985 | 892 | 0.030 |
Why?
|
| CHO Cells | 1 | 2013 | 156 | 0.030 |
Why?
|
| Recombinant Fusion Proteins | 1 | 1996 | 766 | 0.030 |
Why?
|
| Chickens | 1 | 1993 | 636 | 0.030 |
Why?
|
| Cricetinae | 1 | 2013 | 409 | 0.030 |
Why?
|
| Virulence | 1 | 1993 | 262 | 0.030 |
Why?
|
| Recombinant Proteins | 1 | 1996 | 1385 | 0.030 |
Why?
|
| Cesium | 1 | 1992 | 13 | 0.020 |
Why?
|
| Centrifugation, Density Gradient | 1 | 1992 | 97 | 0.020 |
Why?
|
| Hybridomas | 1 | 1992 | 40 | 0.020 |
Why?
|
| Female | 5 | 2021 | 65494 | 0.020 |
Why?
|
| Immunoblotting | 1 | 1992 | 312 | 0.020 |
Why?
|
| Cross Reactions | 1 | 1992 | 192 | 0.020 |
Why?
|
| Protein Structure, Tertiary | 1 | 2013 | 752 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2021 | 6034 | 0.020 |
Why?
|
| Feces | 2 | 1998 | 710 | 0.020 |
Why?
|
| Kidney | 2 | 1993 | 1338 | 0.020 |
Why?
|
| Hemolytic Plaque Technique | 1 | 1987 | 6 | 0.020 |
Why?
|
| Ileum | 1 | 1988 | 132 | 0.020 |
Why?
|
| Rabbits | 2 | 1998 | 696 | 0.020 |
Why?
|
| Sheep | 1 | 1987 | 208 | 0.020 |
Why?
|
| Stomach | 1 | 1988 | 271 | 0.020 |
Why?
|
| Phosphorus Radioisotopes | 1 | 1985 | 17 | 0.020 |
Why?
|
| DNA Mutational Analysis | 1 | 1987 | 793 | 0.020 |
Why?
|
| Membrane Proteins | 1 | 1993 | 1530 | 0.020 |
Why?
|
| Mice, Inbred Strains | 1 | 1986 | 310 | 0.020 |
Why?
|
| Male | 3 | 2021 | 60083 | 0.010 |
Why?
|
| Culture Media | 1 | 1985 | 182 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2015 | 6376 | 0.010 |
Why?
|
| Guinea Pigs | 1 | 1984 | 167 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 1989 | 2114 | 0.010 |
Why?
|
| Hot Temperature | 1 | 1984 | 135 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2021 | 16022 | 0.010 |
Why?
|
| Ultracentrifugation | 1 | 2002 | 20 | 0.010 |
Why?
|
| Protein Structure, Quaternary | 1 | 2002 | 98 | 0.010 |
Why?
|
| Age Factors | 1 | 1988 | 2801 | 0.010 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 1990 | 935 | 0.010 |
Why?
|
| Glycoproteins | 1 | 1982 | 369 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 2013 | 8106 | 0.010 |
Why?
|
| Liver Neoplasms | 1 | 1990 | 1308 | 0.010 |
Why?
|
| Models, Molecular | 1 | 2003 | 1070 | 0.010 |
Why?
|
| Genetic Variation | 2 | 1983 | 1479 | 0.010 |
Why?
|
| Saponins | 1 | 1998 | 22 | 0.010 |
Why?
|
| Aluminum Compounds | 1 | 1998 | 17 | 0.010 |
Why?
|
| Freund's Adjuvant | 1 | 1998 | 26 | 0.010 |
Why?
|
| Phosphates | 1 | 1998 | 111 | 0.010 |
Why?
|
| Injections, Intramuscular | 1 | 1998 | 192 | 0.010 |
Why?
|
| Immunoglobulin A | 1 | 1998 | 197 | 0.010 |
Why?
|
| Virus Shedding | 1 | 1998 | 79 | 0.010 |
Why?
|
| Aged | 1 | 2015 | 19088 | 0.010 |
Why?
|
| Disease Transmission, Infectious | 1 | 1998 | 86 | 0.010 |
Why?
|
| Pregnancy | 1 | 1989 | 7146 | 0.010 |
Why?
|
| Nucleic Acid Conformation | 1 | 1977 | 184 | 0.010 |
Why?
|
| Adjuvants, Immunologic | 1 | 1998 | 375 | 0.010 |
Why?
|
| Middle Aged | 1 | 2015 | 26002 | 0.010 |
Why?
|
| Immunoglobulin G | 1 | 1998 | 770 | 0.010 |
Why?
|
| Myristic Acid | 1 | 1994 | 6 | 0.010 |
Why?
|
| Myristic Acids | 1 | 1994 | 7 | 0.010 |
Why?
|
| Inclusion Bodies, Viral | 1 | 1994 | 11 | 0.010 |
Why?
|
| Sequence Analysis | 1 | 1994 | 54 | 0.010 |
Why?
|
| Desiccation | 1 | 1994 | 43 | 0.010 |
Why?
|
| Osmolar Concentration | 1 | 1994 | 172 | 0.010 |
Why?
|
| Protein Structure, Secondary | 1 | 1994 | 239 | 0.010 |
Why?
|
| Models, Structural | 1 | 1993 | 49 | 0.010 |
Why?
|
| DNA, Complementary | 1 | 1994 | 462 | 0.010 |
Why?
|
| Freezing | 1 | 1993 | 28 | 0.010 |
Why?
|
| Computer Graphics | 1 | 1993 | 38 | 0.010 |
Why?
|
| Macromolecular Substances | 1 | 1993 | 185 | 0.010 |
Why?
|
| Methionine | 1 | 1993 | 102 | 0.010 |
Why?
|
| Chick Embryo | 1 | 1993 | 132 | 0.010 |
Why?
|
| Protein Binding | 1 | 1994 | 1741 | 0.010 |
Why?
|
| Genetic Code | 2 | 1978 | 40 | 0.000 |
Why?
|
| Cell Differentiation | 1 | 1991 | 1907 | 0.000 |
Why?
|
| Carbohydrate Sequence | 1 | 1982 | 17 | 0.000 |
Why?
|
| Protein Precursors | 1 | 1982 | 149 | 0.000 |
Why?
|
| Hemagglutination | 1 | 1978 | 8 | 0.000 |
Why?
|
| Tromethamine | 1 | 1978 | 9 | 0.000 |
Why?
|
| Acetates | 1 | 1978 | 70 | 0.000 |
Why?
|
| Erythrocytes | 1 | 1978 | 206 | 0.000 |
Why?
|
| Glycine | 1 | 1978 | 160 | 0.000 |
Why?
|
| Cytoplasm | 1 | 1978 | 289 | 0.000 |
Why?
|